HHM Wealth Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
CIM
ATO
CGH
HHM Wealth Advisors's GILD Position: Q2 2026 in Review
HHM Wealth Advisors increased its Gilead Sciences (GILD) stake by 8.6% in Q2 2026, buying an estimated $2.77K and bringing the position to 266 shares worth $33.6K. The position accounts for ﹤0.01% of the portfolio, ranked #444.
HHM Wealth Advisors first reported a position in GILD in Q1 2020 and has held it in 26 quarters since. The position peaked at $187K in Q2 2020. 759 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- HHM Wealth Advisors held 266 shares of Gilead Sciences worth $33.6K as of Q2 2026.
- HHM Wealth Advisors bought 21 Gilead Sciences shares in Q2 2026, an estimated $2.77K.
- Gilead Sciences made up ﹤0.01% of HHM Wealth Advisors's portfolio in Q2 2026, its #444 holding.
- HHM Wealth Advisors first reported a position in Gilead Sciences in Q1 2020 and has held it in 26 quarters since.
- HHM Wealth Advisors's Gilead Sciences position peaked at $187K in Q2 2020.
- 759 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on HHM Wealth Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.